课题基金 / 基金详情

Renal Vascular Reactivity in Hypertension

Renal Vascular Reactivity in Hypertension
高血压中的肾血管反应性
批准号:
8050304
负责人:
WILLIAM J ARENDSHORST
金额:
$57.43万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 2014-11-30

项目摘要

项目成果

WILLIAM J ARENDSHORST的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):CD38 ADP核糖基(ADPR)环化酶是一种膜结合酶,其产生的代谢物已知可促进微动脉平滑肌细胞中由ryanodine受体(RyR)介导的Ca2+动员。我们假设肾脏CD38是血管紧张素II (Ang II)诱导的高血压(AIH)发展的核心,CD38缺陷小鼠比野生型(WT)小鼠表现出更不明显的肾脏血管收缩、Na+滞留和AIH。AIM 1验证了CD38 ADPR环化酶参与AIH发展的假设,使得Ang II在CD38-/-(全局遗传缺陷)小鼠中比WT小鼠产生更不明显的高血压。通过siRNA诱导CD38的靶向、肾特异性部分敲低,在WT小鼠中也可以预测较轻的高血压。AIH的严重程度是通过测量清醒、不受约束的小鼠在慢性注射Ang II之前和期间的24小时动脉压(遥测)来确定的。还测量了24小时尿中亚硝酸盐/硝酸盐和8-iso-PGF21的排泄量,以评估一氧化氮(NO)的产生和氧化应激。在肾小球前血管中定量检测CD38 mRNA和ADPR环化酶活性。AIM 2评估CD38 ADPR环化酶对AIH肾血管收缩的贡献以及压力-尿钠关系的右移。我们预测,在AIH的发展过程中,cd38缺陷小鼠的肾脏对急性盐负荷的反应比WT小鼠更快地排泄Na+,排泄率在AIH中变得相似。清醒和麻醉小鼠的CD38全敲除和肾特异性敲除将在两个阶段进行评估。AIM 3评估了CD38是介导G蛋白偶联受体诱导的Ca2+信号通路的主要ADPR环化酶的假设,包括RyR和Ca2+诱导的离体传入小动脉Ca2+释放和体内肾血管收缩。我们预测,在对照组和AIH条件下,cd38缺陷小鼠与WT小鼠相比,Ca2+信号和血管对血管收缩剂(Ang II, ET-1, TxA2)的反应性减弱。放射性配体结合的Scatchard分析将表征Ang II、ET-1和TP受体在肾微血管中的亲和力和/或密度。我们的目标是确定在高血压发生之前或早期发生的一系列事件,因此比继发性压力依赖性后果更有可能是病因。将CD38的基因靶向缺失与ADPR环化酶和ryr介导的Ca2+释放的药理抑制结合起来,将提供重要的新信息,表明CD38是在肾微循环中介导Ca2+信号的主要环化酶家族成员,其在肾血管收缩、Na+保留和AIH发展的长期调节中的功能意义。我们对这一未被充分认识的途径的新研究的成功完成将大大促进我们对肾微循环中Ca2+信号传导的细胞/分子机制的理解,以及健康和疾病中肾血管反应性的调节,对该领域产生重大影响。
英文摘要
DESCRIPTION (provided by applicant): CD38 ADP ribosyl (ADPR) cyclase is a membrane-bound enzyme that produces metabolites known to promote Ca2+ mobilization mediated by ryanodine receptors (RyR) in arteriolar smooth muscle cells. We posit that renal CD38 is central to the development of angiotensin II (Ang II)-induced hypertension (AIH) and that CD38-deficient mice exhibit less pronounced renal vasoconstriction, Na+ retention and AIH than do wild-type (WT) mice. AIM 1 tests the hypothesis that CD38 ADPR cyclase participates in the development of AIH such that Ang II produces less pronounced hypertension in CD38-/- (global genetic deficiency) vs. WT mice. Less severe hypertension is also predicted in WT mice with targeted, renal-specific partial knockdown of CD38 induced by siRNA. The severity of AIH is determined by measuring 24-hr arterial pressure (telemetry) in conscious, unrestrained mice before and during chronic Ang II infusion. Also measured are 24 hr urinary excretion of nitrite/nitrate and 8-iso-PGF21 to assess nitric oxide (NO) production and oxidative stress. CD38 mRNA and ADPR cyclase activity will be quantified in preglomerular vessels. AIM 2 assesses the contribution of CD38 ADPR cyclase to renal vasoconstriction and the rightward shift in the pressure-natriuresis relation in AIH. We predict that the kidneys of CD38-deficient mice excrete Na+ more rapidly in response to an acute salt load than WT mice during development of AIH, with excretion rates becoming similar in established AIH. Conscious and anesthetized mice with global knockout and renal-specific knockdown of CD38 will be evaluated in both phases. AIM 3 evaluates the hypothesis that CD38 is the major ADPR cyclase mediating G- protein coupled receptor-elicited Ca2+ signaling involving RyR and Ca2+-induced Ca2+ release in isolated afferent arterioles and renal vasoconstriction in vivo. We predict that Ca2+ signaling and vascular responsiveness to vasoconstrictor agents (Ang II, ET-1, TxA2) are attenuated in CD38-deficient vs. WT mice during control and AIH conditions. Scatchard analysis of radioligand binding will characterize Ang II, ET-1, and TP receptor affinity and/or density in renal microvessels. Our goal is to identify a sequence of events that precede or occur early during the development of hypertension and thus are more likely to be causative than secondary, pressure-dependent consequences. Combining gene-targeted deletion of CD38, global and renal- specific, with pharmacological inhibition of ADPR cyclase and RyR-mediated Ca2+ release will provide important new information that CD38 is the primary cyclase family member mediating Ca2+ signaling in the renal microcirculation and its functional significance in long-term regulation of renal vasoconstriction, Na+ retention and the development of AIH. Successful completion of our novel studies of this underappreciated pathway will significantly advance our understanding of cellular/molecular mechanisms of Ca2+ signaling in the renal microcirculation and regulation of renal vascular reactivity in health and disease, making a major impact on the field. PUBLIC HEALTH RELEVANCE: More than 70 million Americans have hypertension, a major cardiovascular risk factor, highly predictive of other vascular diseases such as atherosclerosis, diabetes mellitus, renal failure, and stroke. Studies are proposed to investigate mechanisms regulating calcium metabolism in smooth muscle cells that contract blood vessels. Abnormal cell signaling can cause arteries to be hyper-responsive to vasoactive hormones and cause the kidneys to retain inappropriate amounts of salt and water, resulting in an expanded blood volume and the development of high blood pressure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB Conference: Renal Hemodynamics: Biomolecular Control Mechanisms Integrating
Renal Vascular Reactivity in Genetic Hypertension
  • 批准号:
    6890434
  • 项目类别:
  • 资助金额:
    $45.4万
  • 财政年份:
    1986
  • 负责人:
    WILLIAM J ARENDSHORST
  • 依托单位:
Renal Vascular Reactivity in Genetic Hypertension
  • 批准号:
    7143355
  • 项目类别:
  • 资助金额:
    $50.07万
  • 财政年份:
    1986
  • 负责人:
    WILLIAM J ARENDSHORST
  • 依托单位:
MICROPUNCTURE STUDY OF KIDNEY FUNCTION
  • 批准号:
    2026982
  • 项目类别:
  • 资助金额:
    $33.42万
  • 财政年份:
    1986
  • 负责人:
    WILLIAM J ARENDSHORST
  • 依托单位:
海外基金